F2RL3 methylation in blood DNA is a strong predictor of mortality
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Smoking is a major cause of morbidity and mortality. Smoking-related epigenetic biomarkers may open new avenues to better quantify the adverse health effects of smoking, and to better understanding of the underlying mechanisms. We aimed to evaluate the clinical implications of F2RL3 methylation, a novel epigenetic biomarker of smoking exposure disclosed by recent genome-wide methylation studies. METHODS: Blood DNA methylation at F2RL3 (also known as PAR-4) was quantified in baseline samples of 3588 participants aged 50-75 years in a large population-based prospective cohort study by MALDI-TOF mass spectrometry. Deaths were recorded during a median follow-up of 10.1 years. The associations of methylation intensity and of smoking with all-cause, cardiovascular, cancer and other mortality were assessed by Cox's proportional hazards regression, controlling for potential confounding factors. RESULTS: Lower methylation intensity at F2RL3 was strongly associated with mortality. After adjustment for multiple covariates including smoking, hazard ratios [95% confidence interval (CI)] for death from any cause, cardiovascular disease, cancer or other causes were 2.60 (95% CI, 1.81-3.74), 2.45 (95% CI, 1.28-4.68), 2.94 (95% CI, 1.68-5.14) and 2.39 (95% CI, 1.11-5.16), respectively, in subjects in the lowest quartile of methylation intensity compared with subjects in the highest quartile. The associations with mortality outcomes were much stronger among men than among women. In addition, strong positive associations of smoking with each of the outcomes were substantially weakened, and almost disappeared when controlling for F2RL3 methylation intensity. CONCLUSIONS: F2RL3 methylation is a strong predictor of mortality, including all-cause, cardiovascular, cancer and other mortality. Systemic adverse effects of smoking may be mediated by pathways associated with F2RL3 methylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Checking the Cox model with cumulative sums of martingale-based residuals
LIN, D. Y., WEI, L. J., & YING, Z. (1993) · Biometrika · doi:10.1093/biomet/80.3.557 · Cited by 1,432
Tobacco smoking leads to extensive genome-wide changes in DNA methylation
Zeilinger, S., Kühnel, B., Klopp, N., Baurecht, H., Kleinschmidt, A., Gieger, C., Weidinger, S., Lattka, E., Adamski, J., Peters, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063812 · Cited by 824 · cited 1×
“33.(7,36) An alternative or complementary explanation may be that F2RL3 methylation may more accurately reflect the biologically effective current and lifetime dose of smoking than self-reported smoking history and habits that might suffer from wilful misreporting and imperfect recall.”
BackgroundTobacco-smoking-related differential DNA methylation: 27K discovery and replication
Breitling, L. P., Yang, R., Korn, B., Burwinkel, B., & Brenner, H. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.03.003 · Cited by 640
Self-citationShenker, N. S., Polidoro, S., van Veldhoven, K., Sacerdote, C., Ricceri, F., Birrell, M. A., Belvisi, M. G., Brown, R., Vineis, P., & Flanagan, J. M. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds488 · Cited by 396 · cited 3×
“Although methylation intensity may strongly vary between cell types,(42,43) no variation of F2RL3 methylation between various types of leukocytes was found in a recent study among healthy subjects.(7) Moreover smoking, the main determinant of F2RL3 methylation intensities, does not seem to affect the composition of le…”
BackgroundMortality from cancer in relation to smoking: 50 years observations on British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602359 · Cited by 392 · cited 1×
“A large number of longitudinal epidemiological studies have consistently shown strong associations of smoking with all-cause, cardiovascular and cancer mortality.(4,38,39) Although such associations were also found in our study, they were substantially attenuated or even disappeared after adjustment for F2RL3 methylat…”
Petersen, A.-K., Zeilinger, S., Kastenmüller, G., Römisch-Margl, W., Brugger, M., Peters, A., Meisinger, C., Strauch, K., Hengstenberg, C., Pagel, P., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt430 · Cited by 183 · cited 1×
“33 were all associated with 4-vinylphenol, a metabolic indicator of complex disorders.(37) Further research is warranted to address the individual and joint associations of smoking-related DNA methylation patterns with mortality and the underlying mechanisms.”
BackgroundLuminal Cathepsin G and Protease-Activated Receptor 4
Dabek, M., Ferrier, L., Roka, R., Gecse, K., Annahazi, A., Moreau, J., Escourrou, J., Cartier, C., Chaumaz, G., Leveque, M., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080986 · Cited by 73
Cited by
Gao, X., Jia, M., Zhang, Y., Breitling, L. P., & Brenner, H. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0148-3 · Cited by 386
“and lung cancer, as well as to total mortality [26, 27].”
BackgroundDNA methylation signatures in peripheral blood strongly predict all-cause mortality
Zhang, Y., Wilson, R., Heiss, J., Breitling, L. P., Saum, K.-U., Schöttker, B., Holleczek, B., Waldenberger, M., Peters, A., & Brenner, H. (2017) · Nature Communications · doi:10.1038/ncomms14617 · Cited by 382
Self-citationAHRR(cg05575921) hypomethylation marks smoking behaviour, morbidity and mortality
Bojesen, S. E., Timpson, N., Relton, C., Davey Smith, G., & Nordestgaard, B. G. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-208789 · Cited by 172
Sun, Y. V. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0058-2 · Cited by 27
“Several studies also reported an inverse association between pack-years and DNA methylation, and a positive association between time since quitting smoking and DNA methylation [51, 55, 58, 62].”
Metadata
- Authors
- Zhang, Y., Yang, R., Burwinkel, B., Breitling, L. P., Holleczek, B., Schöttker, B., & Brenner, H.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-02-07
- Volume
- 43
- Issue
- 4
- Pages
- 1215-1225
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2108548228
- Cited by
- 101
- References
- 8
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: F2RL3 methylation in blood DNA is a strong predictor of mortality. https://app.cochat.ai/papers/10.1093/ije/dyu006
- The paper
- Zhang, Y., Yang, R., Burwinkel, B., Breitling, L. P., Holleczek, B., Schöttker, B., & Brenner, H. (2014). F2RL3 methylation in blood DNA is a strong predictor of mortality. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyu006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.